BBA
CL icon

BLB&B Advisors’s Colgate-Palmolive CL Stock Holding History

BLB&B Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Hold
2,882
– – 0.01% 253
2025
Q4 		$228K Sell
2,882
-360
-11% -$28.2K 0.01% 265
2025
Q3 		$259K Buy
3,242
+360
+12% +$30.7K 0.01% 244
2025
Q2 		$262K Sell
2,882
-360
-11% -$32.9K 0.01% 236
2025
Q1 		$304K Hold
3,242
– – 0.02% 226
2024
Q4 		$295K Sell
3,242
-810
-20% -$77.3K 0.02% 229
2024
Q3 		$421K Sell
4,052
-285
-7% -$29K 0.02% 191
2024
Q2 		$421K Buy
4,337
+104
+2% +$9.59K 0.02% 189
2024
Q1 		$381K Hold
4,233
– – 0.02% 203
2023
Q4 		$337K Sell
4,233
-1
-0% -$75 0.02% 198
2023
Q3 		$301K Buy
4,234
+687
+19% +$51.4K 0.02% 188
2023
Q2 		$273K Sell
3,547
-450
-11% -$34.8K 0.02% 214
2023
Q1 		$300K Sell
3,997
-180
-4% -$13.4K 0.02% 191
2022
Q4 		$329K Hold
4,177
– – 0.03% 188
2022
Q3 		$293K Sell
4,177
-200
-5% -$15.7K 0.02% 189
2022
Q2 		$351K Sell
4,377
-266
-6% -$20.8K 0.03% 182
2022
Q1 		$352K Sell
4,643
-124
-3% -$9.82K 0.02% 199
2021
Q4 		$407K Sell
4,767
-2,142
-31% -$167K 0.03% 191
2021
Q3 		$522K Buy
6,909
+148
+2% +$11.8K 0.03% 182
2021
Q2 		$550K Buy
6,761
+1,396
+26% +$114K 0.04% 165
2021
Q1 		$423K Sell
5,365
-100
-2% -$7.84K 0.03% 179
2020
Q4 		$467K Sell
5,465
-3,024
-36% -$250K 0.04% 177
2020
Q3 		$655K Hold
8,489
– – 0.07% 136
2020
Q2 		$622K Hold
8,489
– – 0.07% 141
2020
Q1 		$563K Sell
8,489
-100
-1% -$7.05K 0.07% 146
2019
Q4 		$591K Buy
8,589
+69
+0.8% +$4.7K 0.06% 171
2019
Q3 		$626K Sell
8,520
-750
-8% -$54.4K 0.07% 169
2019
Q2 		$664K Sell
9,270
-1,000
-10% -$71K 0.08% 167
2019
Q1 		$704K Sell
10,270
-2,180
-18% -$141K 0.08% 160
2018
Q4 		$741K Sell
12,450
-4,478
-26% -$280K 0.1% 145
2018
Q3 		$1.13M Buy
16,928
+2,238
+15% +$149K 0.14% 120
2018
Q2 		$952K Buy
14,690
+500
+4% +$32.7K 0.13% 134
2018
Q1 		$1.02M Sell
14,190
-700
-5% -$50.4K 0.14% 131
2017
Q4 		$1.12M Hold
14,890
– – 0.16% 125
2017
Q3 		$1.08M Sell
14,890
-880
-6% -$63.4K 0.17% 120
2017
Q2 		$1.17M Hold
15,770
– – 0.19% 112
2017
Q1 		$1.15M Sell
15,770
-150
-0.9% -$10.5K 0.2% 111
2016
Q4 		$1.04M Buy
15,920
+690
+5% +$47.3K 0.18% 117
2016
Q3 		$1.13M Buy
15,230
+73
+0.5% +$5.4K 0.21% 107
2016
Q2 		$1.11M Buy
15,157
+6,800
+81% +$484K 0.21% 110
2016
Q1 		$590K Buy
8,357
+627
+8% +$41.7K 0.12% 151
2015
Q4 		$515K Sell
7,730
-74
-0.9% -$4.92K 0.11% 156
2015
Q3 		$495K Buy
7,804
+1,500
+24% +$98K 0.11% 156
2015
Q2 		$412K Sell
6,304
-1,000
-14% -$67.8K 0.09% 179
2015
Q1 		$506K Sell
7,304
-90
-1% -$6.22K 0.11% 152
2014
Q4 		$512K Hold
7,394
– – 0.11% 158
2014
Q3 		$482K Buy
7,394
+2,400
+48% +$158K 0.1% 169
2014
Q2 		$340K Sell
4,994
-1,800
-26% -$121K 0.07% 210
2014
Q1 		$441K Hold
6,794
– – 0.1% 187
2013
Q4 		$443K Sell
6,794
-190
-3% -$12.2K 0.11% 164
2013
Q3 		$414K Sell
6,984
-450
-6% -$26.7K 0.11% 162
2013
Q2 		$426K Buy
+7,434
New +$441K 0.12% 156

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BLB&B Advisors's CL Position: Q1 2026 in Review

BLB&B Advisors held its Colgate-Palmolive (CL) position steady in Q1 2026 at 2,882 shares worth $246K. The position accounts for 0.01% of the portfolio, ranked #253.

BLB&B Advisors first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.17M in Q2 2017. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • BLB&B Advisors held 2,882 shares of Colgate-Palmolive worth $246K as of Q1 2026.
  • BLB&B Advisors left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up 0.01% of BLB&B Advisors's portfolio in Q1 2026, its #253 holding.
  • BLB&B Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • BLB&B Advisors's Colgate-Palmolive position peaked at $1.17M in Q2 2017.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on BLB&B Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.